Compounding pharmacies in Wyoming

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

The Wyoming State Board of Pharmacy regulates compounding pharmacies in Wyoming. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Wyoming at a glance

Pharmacy regulator: Wyoming State Board of Pharmacy
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async unclear
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Wyoming

No verified compounding pharmacies serving Wyoming are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Wyoming

The Wyoming State Board of Pharmacy licenses pharmacies under the Wyoming Pharmacy Act (Wyoming Statutes title 33, chapter 24) and the Board's rules. Section 33-24-152 requires a nonresident pharmacy that dispenses to Wyoming patients to hold a Wyoming license, stay licensed in its home state, keep readily retrievable records of controlled substances and dangerous drugs dispensed to Wyoming patients, comply with the Wyoming generic substitution requirements, and offer a toll-free pharmacist line at least six days and 40 hours a week; the Board may deny, suspend, or revoke the license and assess penalties of up to $2,000 per violation. Compounding is governed by chapter 22 (Compounding) of the Board's Pharmacy Act rules, effective August 19, 2025, which replaced the repealed chapter 13 (non-sterile compounding) and chapter 17 (sterile compounding). Chapter 22 applies to all licensees and adopts by reference USP-NF general chapters 795 (non-sterile), 797 (sterile), 800 (hazardous drugs), and 825 (radiopharmaceuticals) as minimum standards; a 2026 amendment proposed by the Board only fixes the reference date to USP-NF 2024, Issue 1 (official May 1, 2024). Chapter 22 does not set a state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [4] [5] [6] [7]

Compounded GLP-1 access in Wyoming

Because rural Wyoming patients often rely on mail order, the practical check is that the shipping pharmacy holds a Wyoming nonresident pharmacy license under section 33-24-152. [1] [6] [9]

Research use only sellers in Wyoming

The Wyoming Pharmacy Act (title 33, chapter 24) limits dispensing of prescription drugs to licensed pharmacies, including licensed nonresident pharmacies, so a seller shipping "research use only" injectable peptides to Wyoming consumers is outside the licensed channel. [5] [10]

How to check a compounding pharmacy in Wyoming

Search the Wyoming State Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Wyoming requires before it ships to you. [1] [2] [3] [4] [5] [6] [7]
Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Wyoming. [5] [10]

Common questions in Wyoming

What does an out-of-state pharmacy need to ship compounded peptides to Wyoming?

A Wyoming nonresident pharmacy license under section 33-24-152. The pharmacy must remain licensed in its home state, keep records of drugs dispensed to Wyoming patients, and provide a toll-free line to a pharmacist at least 40 hours a week. The Board can fine violations up to $2,000 each. [1] [6]

Can a Wyoming pharmacy compound peptides that are not on the FDA bulks list?

Generally no. Wyoming has no state bulks list, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides in FDA Category 2 cannot be compounded. [2] [7] [8]

All peptide legal questions for Wyoming